Century Sage Scientific Holdings Limited provided earnings guidance for the year ended 31 December 2014. For the year, the company expected to have a growth in net profit as compared to that for the year ended 31 December 2013. Benefiting from the increase of the business during the current period, the Board expects a growth of over 25% in the net profit of the Group in the current period as compared to that of the corresponding period, based on the information currently available to the Board.

When excluding the one-off IPO expenses incurred in the Current Period, the Board expects a growth of over 45% in net profit of the Group in the current period compared to that of the corresponding period. Major factors attributable to the increase in net profit of the Group in the Current Period include: the increase of revenue of all segments generated by the general increase of business of the Group as a result of the increase of the number of contracts completed; and the decrease of the expenses (excluding the one-off IPO expenses) due to the implementation of the expense control.